Michal Vrablik M.D., Ph.D. is a Professor of Internal Medicine at the 1st Faculty of Medicine, Charles University in Prague, the Czech Republic. His main interests include preventive cardiology, clinical lipidology, and genetics of lipoprotein metabolism disorders.
He is the chairman of the Czech Atherosclerosis Society, member of board of the Czech Society of Internal Medicine and the chairman of the Czech Association of Preventive Cardiology of the Czech Society of Cardiology. He is the head of the National centre of the FH screening MedPed program.
He served as a member of the Executive Committee of the European Atherosclerosis Society between 2012 and 2016, currently he continues cooperation with EAS as a member of its Educational Platform Committee. In 2018 he joined the steering committee of the International Lipid Expert Panel. He closely cooperates with the International Atherosclerosis Society being the chair of IAS Regional Federation for Europe since January 2019.
He served as the president of the 85th Congress of European Atherosclerosis Society held in Prague in 2017.
Dr. Vrablik has authored and co-authored more than 400 papers in peer-reviewed scientific journals. He is a member of editorial board and a reviewer for several national and international journals.